Research summary, original research, 2021

Prevalence of Breast Cancer in Female Physicians Performing Procedures With Significant Fluoroscopy Exposure: Survey

Biglione B, Nakhaei M, Hamilton B, Englander MJ, Dua A, Brook OR. Journal of computer assisted tomography. 2021

Read the original paper

In plain language

In a self-reported survey, women physicians with more than 10 years in fluoroscopy-heavy specialties reported breast cancer at a rate similar to those in low-fluoroscopy specialties (16% vs 18%). The groups were small, and the survey did not measure dose.

At a glance

Type of study
Original research, Cross-sectional survey
Who was studied
Other physicians
Size
n = 93 female physicians with >10 years of postfellowship practice (comparison groups; 303 total respondents)
Summary based on
the abstract

What it found

  • Self-reported breast cancer prevalence did not differ between women physicians with more than 10 years of practice in heavy-fluoroscopy specialties and those in low-fluoroscopy specialties.

    Key figures: 8 (16%) of 49 vs 8 (18%) of 44; P = 0.81

  • Breast cancer risk factors were distributed similarly between the two groups.

  • 303 women physicians took part in the survey; 93 (49 and 44) formed the two comparison groups.

    Key figures: 303 participants; 49 and 44 in comparison groups

Limits to keep in mind

The data are self-reported from a survey link shared with self-identified physicians, so selection and recall bias are possible. The comparison groups were small (49 and 44) and underpowered, and exposure was defined by specialty rather than measured dose.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.